Krueger Christopher W 4
4 · Ventyx Biosciences, Inc. · Filed Dec 21, 2023
Insider Transaction Report
Form 4
Krueger Christopher W
Chief Business Officer
Transactions
- Sale
Common Stock
2023-12-20$2.12/sh−5,293$11,210→ 282,119 total
Footnotes (2)
- [F1]Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]Represents the weighted average share price of an aggregate total of 5,293 shares sold in the price range of $2.07 to $2.155. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.